
    
      This trial is a multicentre, randomized, comparative, open label clinical study conducted in
      vascular medicine centres in France, with 2 parallel groups of 100 patients each. The study
      will be conducted in patients suffering from venous leg ulcer (stage C6 of the CEAP
      classification for chronic venous disorders).

      The patients will be randomised at the inclusion: they will receive with either Kit Biflex®
      or the reference device (Profore®) for maximum 16 weeks (or until full healing).

      Investigator assessments are planned every 4 weeks +/- 3 days, for 16 weeks.
    
  